Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

MeSH terms

• Adult
• Aged
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Female
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology
• Leukemia, Myeloid, Acute / chemically induced*
• Leukemia, Myeloid, Acute / diagnosis
• Leukemia, Myeloid, Acute / epidemiology
• Lymphoma, Non-Hodgkin / diagnosis
• Lymphoma, Non-Hodgkin / drug therapy*
• Lymphoma, Non-Hodgkin / epidemiology
• Male
• Middle Aged
• Myelodysplastic Syndromes / chemically induced*
• Myelodysplastic Syndromes / diagnosis
• Myelodysplastic Syndromes / epidemiology
• Neoplasms, Second Primary / chemically induced
• Neoplasms, Second Primary / diagnosis
• Neoplasms, Second Primary / epidemiology
• Prognosis
• Retrospective Studies
• Thailand / epidemiology
• Vidarabine / adverse effects
• Vidarabine / analogs & derivatives*
• Vidarabine / therapeutic use
• Young Adult